N/A
Manufactured by Amneal Pharmaceuticals LLC
11,560 FDA adverse event reports analyzed
Last updated: 2026-04-15
NORETHINDRONE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amneal Pharmaceuticals LLC. The most commonly reported adverse reactions for NORETHINDRONE include NAUSEA, HEADACHE, HOT FLUSH, FATIGUE, DRUG INEFFECTIVE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for NORETHINDRONE.
Out of 5,341 classified reports for NORETHINDRONE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 11,560 FDA FAERS reports that mention NORETHINDRONE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include NAUSEA, HEADACHE, HOT FLUSH, FATIGUE, DRUG INEFFECTIVE, PAIN. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Amneal Pharmaceuticals LLC in connection with NORETHINDRONE. Always verify the specific product and NDC with your pharmacist.